Artiva Biotherapeutics, Inc.·4

Feb 28, 5:15 PM ET

Graef Thorsten 4

4 · Artiva Biotherapeutics, Inc. · Filed Feb 28, 2025

Insider Transaction Report

Form 4
Period: 2025-02-26
Graef Thorsten
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2025-02-26+60,00080,000 total
Footnotes (1)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.

Documents

1 file
  • 4
    form4-02282025_050209.xmlPrimary